Background Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR)
may still occur in as many as 2–10% of percutaneous coronary interventions (PCI) in certain …

Over the course of the 3 decades, percutaneous coronary intervention (PCI) with stent
implantation transformed the practice of cardiology. PCI with stenting is currently the most …

In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

Background Percutaneous coronary intervention (PCI) is a common treatment for patients
with coronary heart disease, and intra-stent restenosis (ISR) is a serious complication after …

Coronary stent implantation has significantly improved percutaneous coronary intervention
and enabled the management of early complications of plain balloon angioplasty. However …

The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …

Background Percutaneous coronary intervention (PCI) with drug-eluting stents is the
standard of care for treatment of native coronary artery stenoses, but optimum treatment …

Management of patients with in-stent restenosis (ISR) remains an important clinical problem.
Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment …

Introduction: Although drug-eluting stents (DES) have significantly reduced the incidence
and prevalence of coronary in-stent restenosis (ISR), ISR still occurs in approximately 10 …

Aims Consensus is lacking regarding the best treatment for coronary in-stent restenosis
(ISR). The two most effective treatments are angioplasty with paclitaxel-coated balloon …